Hogan C - Search Results

1

Cytomegalovirus disease in immunocompetent adults.

Lancini D, Faddy HM, Flower R, Hogan C. Lancini D, et al. Among authors: hogan c. Med J Aust. 2014 Nov 17;201(10):578-80. doi: 10.5694/mja14.00183. Med J Aust. 2014. PMID: 25390262 Review.

2

Cytomegalovirus in Australian blood donors: seroepidemiology and seronegative red blood cell component inventories.

Lancini DV, Faddy HM, Ismay S, Chesneau S, Hogan C, Flower RL. Lancini DV, et al. Among authors: hogan c. Transfusion. 2016 Jun;56(6 Pt 2):1616-21. doi: 10.1111/trf.13459. Epub 2016 Jan 22. Transfusion. 2016. PMID: 26801676

3

Barriers to delivering asthma care: a qualitative study of general practitioners.

Goeman DP, Hogan CD, Aroni RA, Abramson MJ, Sawyer SM, Stewart K, Sanci LA, Douglass JA. Goeman DP, et al. Med J Aust. 2005 Nov 7;183(9):457-60. doi: 10.5694/j.1326-5377.2005.tb07122.x. Med J Aust. 2005. PMID: 16274345

4

A national review of the clinical use of group O D- red blood cell units.

Hirani R, Wong J, Diaz P, Mondy P, Hogan C, Dennington PM, Pink J, Irving DO. Hirani R, et al. Among authors: hogan c. Transfusion. 2017 May;57(5):1254-1261. doi: 10.1111/trf.14012. Epub 2017 Feb 1. Transfusion. 2017. PMID: 28150349

5

Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline.

Compernolle V, Chou ST, Tanael S, Savage W, Howard J, Josephson CD, Odame I, Hogan C, Denomme G, Shehata N; International Collaboration for Transfusion Medicine Guidelines. Compernolle V, et al. Among authors: hogan c. Transfusion. 2018 Jun;58(6):1555-1566. doi: 10.1111/trf.14611. Epub 2018 Apr 26. Transfusion. 2018. PMID: 29697146 Review.

6

National ethics committee urgently needed.

Hogan CD. Hogan CD. Med J Aust. 2003 Apr 21;178(8):416. doi: 10.5694/j.1326-5377.2003.tb05274.x. Med J Aust. 2003. PMID: 12697023 No abstract available.

7

More than task substitution and transfer.

Hogan CD. Hogan CD. Med J Aust. 2006 Nov 20;185(10):575. doi: 10.5694/j.1326-5377.2006.tb00698.x. Med J Aust. 2006. PMID: 17115974 No abstract available.

8

Communication overload.

Hogan CD. Hogan CD. Med J Aust. 2002 Dec 2-16;177(11-12):688. doi: 10.5694/j.1326-5377.2002.tb05026.x. Med J Aust. 2002. PMID: 12464007 No abstract available.

9

Warfarin ineffective as symptomatic therapy for erythropoietic protoporphyria.

Doolan BJ, Vu M, Varigos GA, Hogan C, Ross G, Sood S, Winship I. Doolan BJ, et al. Among authors: hogan c. Australas J Dermatol. 2019 Nov;60(4):e360-e361. doi: 10.1111/ajd.13033. Epub 2019 Mar 27. Australas J Dermatol. 2019. PMID: 30916386 No abstract available.

10

Antioxidant effect of warfarin therapy: a possible symptomatic treatment for erythropoietic protoporphyria.

Winship I, Ross G, Nicoll A, Hogan C, Leong Y, Varigos G. Winship I, et al. Among authors: hogan c. Arch Dermatol. 2009 Aug;145(8):960-1. doi: 10.1001/archdermatol.2009.165. Arch Dermatol. 2009. PMID: 19687444 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

753 results

Search Page